|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168 00020
|
$5,855,332
|
Hoover, Robert
|
DCEG (NCI)
|
|
University of Virginia Cancer Center Support Grant
|
5P30CA044579-27
|
$2,599,349
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-08
|
$1,870,359
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156734-08
|
$1,691,502
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,540,531
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
Chromatin Structure and Gene Expression
|
ZIA BC 005450
|
$1,340,986
|
Hager, Gordon
|
CCR (NCI)
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
|
4R44CA217587-02
|
$1,165,750
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
UCLA SPORE in Prostate Cancer
|
3P50CA092131-15S1
|
$1,162,609
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
SPORE in Genitourinary Cancer
|
3P50CA091846-15S1
|
$1,162,609
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Breast Cancer
|
3P50CA098131-16S1
|
$1,162,609
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
|
3U01DK108328-04S2
|
$1,000,000
|
YUAN, YING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
|
4R44CA224994-02
|
$749,974
|
NEDERLOF, MICHEL
|
QUANTITATIVE IMAGING SYSTEMS, LLC
|
|
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors
|
4R44CA217528-02
|
$710,496
|
SRINIVASAN, RAVI
|
ONCONANO MEDICINE, INC.
|
|
A real-time, cost-effective, accurate UV measurement and sun protection system to prevent and reduce the incidence of sunburn in high-risk consumers.
|
4R44CA224658-02
|
$686,491
|
MEITL, MATTHEW
|
WEARIFI, INC.
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$648,792
|
Vocke, Cathy
|
CCR (NCI)
|
|
Identification and Functional Characterization of Melanoma and Other Cancer Risk
|
ZIA CP010201 10570
|
$646,019
|
Brown, Kevin
|
DCEG (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$553,378
|
Pinto, Peter
|
CCR (NCI)
|
|
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
|
7R01CA215403-02
|
$551,568
|
NYITRAY, ALAN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
HIV, HERV-K and Human Cancer
|
5R01CA206275-02
|
$524,710
|
HAMMARSKJOLD, MARIE-LOUISE
|
UNIVERSITY OF VIRGINIA
|
|
DNA Methylation Inhibitor Therapy for Testicular Cancer
|
1R01CA211875-01A1
|
$503,327
|
SPINELLA, MICHAEL
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
SPORE in Skin Cancer
|
3P50CA121973-10S2
|
$500,000
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Screening to identify protectors and mitigators of Radiation GI Syndrome
|
ZIA BC 011762
|
$472,836
|
Citrin, Deborah
|
CCR (NCI)
|
|
Molecular origins and evolution to chemoresistance in germ cell tumors
|
1R37CA222574-01
|
$407,175
|
VAN ALLEN, ELIEZER
|
DANA-FARBER CANCER INST
|
|
Multilevel Resilience Trajectories in the Transition to Cancer Survivorship
|
4UH3CA220642-02
|
$402,405
|
PARK, CRYSTAL
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
In vivo Imaging Analysis of Steroid-Nuclear Receptor Function
|
ZIA BC 010308
|
$383,139
|
Hager, Gordon
|
CCR (NCI)
|
|
Circulating plasma tumor DNA as a biomarker for early stage breast cancer
|
7R01CA194024-03
|
$378,539
|
PARK, BEN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
3U24CA180803-05S1
|
$335,460
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Cancer Therapy-induced Long-term Bone Marrow Injury
|
7R01CA122023-11
|
$308,813
|
ZHOU, DAOHONG
|
UNIVERSITY OF FLORIDA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-38S4
|
$300,000
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S8
|
$293,284
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA013696-44S9
|
$250,000
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Studying the initiation, progression and therapy of lung cancer in mouse models
|
3R01CA131261-09S2
|
$249,999
|
MCMAHON, MARTIN
|
UNIVERSITY OF UTAH
|
|
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk
|
4R00CA207872-03
|
$248,995
|
RYSER, MARC
|
DUKE UNIVERSITY
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S1
|
$247,355
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Clinical and genetic studies of familial testicular cancer
|
ZIA CP010144 07070
|
$244,757
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
3P30CA042014-29S9
|
$228,331
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Physical Activity Platform to Improve Bone Health in Cancer Survivors
|
6R43CA224412-02
|
$224,098
|
SKINNER, CATHERINE
|
THRIVORS, INC.
|
|
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
|
3R44CA200186-03S1
|
$209,717
|
HUMBLET, VALERIE
|
COLLAGEN MEDICAL, LLC
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S2
|
$188,884
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S5
|
$174,039
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|